{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:18:10Z","timestamp":1707524290995},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,27]]},"DOI":"10.7759\/cureus.15965","type":"journal-article","created":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T16:53:00Z","timestamp":1624812780000},"source":"Crossref","is-referenced-by-count":0,"title":["Metachronous Renal Cell Carcinoma: A Rare Presentation of Adrenal Crisis"],"prefix":"10.7759","author":[{"given":"Andrew V","family":"Doodnauth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Hamza","family":"Bin Waqar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam M","family":"Klar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohra R","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samy I","family":"McFarlane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1279","article-title":"Epidemiology of renal cell carcinoma","volume":"11","author":"Padala SA","year":"2020","unstructured":"Padala SA, Barsouk A, Thandra KC, et al.. Epidemiology of renal cell carcinoma. World J Oncol. 2020, 11:79-87. 10.14740\/wjon1279","journal-title":"World J Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2019.03.049","article-title":"Solitary contralateral adrenal metastasis of renal cell carcinoma 15 years following radical nephrectomy: a case report and review of literature","volume":"58","author":"Ahmed HK","year":"2019","unstructured":"Ahmed HK, Bapir R, Abdula GF, Hassan KMS, Ali RM, Salih MA. Solitary contralateral adrenal metastasis of renal cell carcinoma 15 years following radical nephrectomy: a case report and review of literature. Int J Surg Case Rep. 2019, 58:33-6. 10.1016\/j.ijscr.2019.03.049","journal-title":"Int J Surg Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034626","article-title":"What is the optimum systemic treatment for advanced\/metastatic renal cell carcinoma of favourable, intermediate and poor risk, respectively? A systematic review and network meta-analysis","volume":"10","author":"Cao G","year":"2020","unstructured":"Cao G, Wu X, Wang Z, et al.. What is the optimum systemic treatment for advanced\/metastatic renal cell carcinoma of favourable, intermediate and poor risk, respectively? A systematic review and network meta-analysis. BMJ Open. 2020, 10:e034626. 10.1136\/bmjopen-2019-034626","journal-title":"BMJ Open"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.7398","article-title":"Cabozantinib versus sunitinib as initial targeted therapy for patients with metastatic renal cell carcinoma of poor or intermediate risk: the Alliance A031203 CABOSUN trial","volume":"35","author":"Choueiri TK","year":"2017","unstructured":"Choueiri TK, Halabi S, Sanford BL, et al.. Cabozantinib versus sunitinib as initial targeted therapy for patients with metastatic renal cell carcinoma of poor or intermediate risk: the Alliance A031203 CABOSUN trial. J Clin Oncol. 2017, 35:591-7. 10.1200\/JCO.2016.70.7398","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.18999\/nagjms.80.2.285","article-title":"Refractory hypotension due to Nivolumab-induced adrenal insufficiency","volume":"80","author":"Tsukizawa Y","year":"2018","unstructured":"Tsukizawa Y, Kondo K, Ichiba T, Naito H, Mizuki K, Masuda K. Refractory hypotension due to Nivolumab-induced adrenal insufficiency. Nagoya J Med Sci. 2018, 80:285-8. 10.18999\/nagjms.80.2.285","journal-title":"Nagoya J Med Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2019.1696581","article-title":"Adrenal insufficiency due to recurrent renal cell carcinoma in the left adrenal gland 3 years after right radical nephrectomy for renal cell carcinoma","volume":"132","author":"Lee MW","year":"2020","unstructured":"Lee MW, Lee HJ. Adrenal insufficiency due to recurrent renal cell carcinoma in the left adrenal gland 3 years after right radical nephrectomy for renal cell carcinoma. Postgrad Med. 2020, 132:301-3. 10.1080\/00325481.2019.1696581","journal-title":"Postgrad Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-017-0662-1","article-title":"Metastases of renal cell carcinoma to the contralateral adrenal gland managed by laparoscopic adrenalectomy","volume":"8","author":"Nerli RB","year":"2017","unstructured":"Nerli RB, Patil SM, Pathade A, Patil RA, Pingale ND, Malur PR. Metastases of renal cell carcinoma to the contralateral adrenal gland managed by laparoscopic adrenalectomy. Indian J Surg Oncol. 2017, 8:326-30. 10.1007\/s13193-017-0662-1","journal-title":"Indian J Surg Oncol"},{"key":"ref8","article-title":"Challenges in RCC imaging: renal insufficiency, post-operative surveillance, and the role of radiomics","volume":"13","author":"Farber NJ","year":"2015","unstructured":"Farber NJ, Wu Y, Zou L, Belani P, Singer EA. Challenges in RCC imaging: renal insufficiency, post-operative surveillance, and the role of radiomics. Kidney Cancer J. 2015, 13:84-90.","journal-title":"Kidney Cancer J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.02.027","article-title":"Management of the adrenal gland during partial nephrectomy","volume":"181","author":"Lane BR","year":"2009","unstructured":"Lane BR, Tiong HY, Campbell SC, et al.. Management of the adrenal gland during partial nephrectomy. J Urol. 2009, 181:2430-6. 10.1016\/j.juro.2009.02.027","journal-title":"J Urol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71222-7","article-title":"The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study","volume":"16","author":"Ko JJ","year":"2015","unstructured":"Ko JJ, Xie W, Kroeger N, et al.. The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study. Lancet Oncol. 2015, 16:293-300. 10.1016\/S1470-2045(14)71222-7","journal-title":"Lancet Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816714","article-title":"Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma","volume":"380","author":"Rini BI","year":"2019","unstructured":"Rini BI, Plimack ER, Stus V, et al.. Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma. N Engl J Med. 2019, 380:1116-27. 10.1056\/NEJMoa1816714","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1712126","article-title":"Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma","volume":"378","author":"Motzer RJ","year":"2018","unstructured":"Motzer RJ, Tannir NM, McDermott DF, et al.. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma. N Engl J Med. 2018, 378:1277-90. 10.1056\/NEJMoa1712126","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/61623-metachronous-renal-cell-carcinoma-a-rare-presentation-of-adrenal-crisis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:25:27Z","timestamp":1707506727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/61623-metachronous-renal-cell-carcinoma-a-rare-presentation-of-adrenal-crisis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,27]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.15965","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,27]]}}}